SAN FRANCISCO – The full cohort of the CLASP IID randomized controlled trial continued to show noninferiority of transcatheter edge-to-edge repair (TEER) with the PASCAL system to TEER with the MitraClip system in prohibitive-surgical-risk patients with degenerative mitral regurgitation (DMR), new results show.